Effect of different antidiabetic medications on atherosclerotic cardiovascular disease (ASCVD) risk score among patients with type-2 diabetes mellitus: A multicenter non-interventional observational study.
Syed Wasif GillaniSyed Azhar Syed SulaimanVineetha MenonNazeerullah RahamathullahRiham Mohamed ElshafieHassaan Anwer RathorePublished in: PloS one (2022)
The study concluded that significant effect of Dipeptidyl peptidase-4 inhibitor on reduction of hospitalization, lipid profile and also ASCVD risk score of type-II diabetes mellitus patients regardless of clinical comorbidities. Also, sulfonylurea combinations have showed significant reduction in LDL and triglycerides values.